FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210601188> ?p ?o ?g. }

• W3210601188 endingPage "78" @default.
• W3210601188 startingPage "69" @default.
• W3210601188 abstract "Introduction Doravirine (DOR) is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) that retains activity against common NNRTI resistance mutations. In this study, we aimed to investigate the prevalence of DOR resistance mutations compared with that of resistance mutations for other NNRTIs among HIV-1-infected treatment‐experienced and -naïve patients from Poland. Methods Resistance to DOR and other NNRTIs was assessed in two datasets: 1760 antiretroviral treatment-naïve HIV-1 patients and 200 treatment‐experienced patients. All 1960 sequences were derived from the patients using bulk sequencing. For resistance analyses, Stanford HIV drug resistance database scores were used. Results Overall, DOR resistance was present in 32 patients (1.62%), of whom 13 (0.74%) were naïve and 19 (9.50%) were treatment-experienced. The most common DOR resistance mutations observed among the naïve patients were A98G and K101E (0.2% each), and those among cART-experienced patients were L100I (2.0%), K101E, V108I, H221Y, and P225H (1.5% each). Furthermore, among the naïve patients, less common resistance to DOR (0.7%) compared with that to nevirapine (NVP) (2.1%; p = 0.0013) and rilpivirine (5.40%; p < 0.0001) was observed. For sequences obtained from treatment-experienced patients, the frequency of resistance to DOR (9.5%) was lower than that for efavirenz (25.5%; p < 0.0001) and NVP (26.0%; p < 0.0001). Conclusions The frequency of transmitted drug resistance to DOR is low, allowing for effective treatment of antiretroviral treatment-naïve patients and rapid treatment initiation. In cART-experienced patients, this agent remains an attractive NNRTI option with a higher genetic barrier to resistance." @default.
• W3210601188 created "2021-11-08" @default.
• W3210601188 creator A5001859689 @default.
• W3210601188 creator A5006383042 @default.
• W3210601188 creator A5007926047 @default.
• W3210601188 creator A5009863043 @default.
• W3210601188 creator A5027906993 @default.
• W3210601188 creator A5038727368 @default.
• W3210601188 creator A5042914476 @default.
• W3210601188 creator A5044337346 @default.
• W3210601188 creator A5073946151 @default.
• W3210601188 creator A5089364962 @default.
• W3210601188 date "2021-05-01" @default.
• W3210601188 modified "2023-10-18" @default.
• W3210601188 title "Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)–infected patients" @default.
• W3210601188 cites W1861169541 @default.
• W3210601188 cites W1867188112 @default.
• W3210601188 cites W2025935798 @default.
• W3210601188 cites W2032471209 @default.
• W3210601188 cites W2044760328 @default.
• W3210601188 cites W2046828783 @default.
• W3210601188 cites W2067293915 @default.
• W3210601188 cites W2077754502 @default.
• W3210601188 cites W2084302660 @default.
• W3210601188 cites W2102563101 @default.
• W3210601188 cites W2107077764 @default.
• W3210601188 cites W2109046728 @default.
• W3210601188 cites W2129228641 @default.
• W3210601188 cites W2151768713 @default.
• W3210601188 cites W2160877552 @default.
• W3210601188 cites W2170218446 @default.
• W3210601188 cites W2256825639 @default.
• W3210601188 cites W2328594556 @default.
• W3210601188 cites W2444168047 @default.
• W3210601188 cites W2462213043 @default.
• W3210601188 cites W2475857717 @default.
• W3210601188 cites W2508295414 @default.
• W3210601188 cites W2522770919 @default.
• W3210601188 cites W2734932982 @default.
• W3210601188 cites W2773554166 @default.
• W3210601188 cites W2792742326 @default.
• W3210601188 cites W2889157553 @default.
• W3210601188 cites W2889612530 @default.
• W3210601188 cites W2897642221 @default.
• W3210601188 cites W2905212625 @default.
• W3210601188 cites W2944046341 @default.
• W3210601188 cites W2971369227 @default.
• W3210601188 cites W2986321983 @default.
• W3210601188 cites W3002151074 @default.
• W3210601188 cites W3007956423 @default.
• W3210601188 cites W3071645158 @default.
• W3210601188 doi "https://doi.org/10.1177/13596535211043044" @default.
• W3210601188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35485331" @default.
• W3210601188 hasPublicationYear "2021" @default.
• W3210601188 type Work @default.
• W3210601188 sameAs 3210601188 @default.
• W3210601188 citedByCount "3" @default.
• W3210601188 countsByYear W32106011882022 @default.
• W3210601188 countsByYear W32106011882023 @default.
• W3210601188 crossrefType "journal-article" @default.
• W3210601188 hasAuthorship W3210601188A5001859689 @default.
• W3210601188 hasAuthorship W3210601188A5006383042 @default.
• W3210601188 hasAuthorship W3210601188A5007926047 @default.
• W3210601188 hasAuthorship W3210601188A5009863043 @default.
• W3210601188 hasAuthorship W3210601188A5027906993 @default.
• W3210601188 hasAuthorship W3210601188A5038727368 @default.
• W3210601188 hasAuthorship W3210601188A5042914476 @default.
• W3210601188 hasAuthorship W3210601188A5044337346 @default.
• W3210601188 hasAuthorship W3210601188A5073946151 @default.
• W3210601188 hasAuthorship W3210601188A5089364962 @default.
• W3210601188 hasBestOaLocation W32106011881 @default.
• W3210601188 hasConcept C104317684 @default.
• W3210601188 hasConcept C114851261 @default.
• W3210601188 hasConcept C126322002 @default.
• W3210601188 hasConcept C142462285 @default.
• W3210601188 hasConcept C156719811 @default.
• W3210601188 hasConcept C159047783 @default.
• W3210601188 hasConcept C182707283 @default.
• W3210601188 hasConcept C2776452011 @default.
• W3210601188 hasConcept C2777351918 @default.
• W3210601188 hasConcept C2778723075 @default.
• W3210601188 hasConcept C2779130552 @default.
• W3210601188 hasConcept C2780727368 @default.
• W3210601188 hasConcept C2781432083 @default.
• W3210601188 hasConcept C2993143319 @default.
• W3210601188 hasConcept C3013748606 @default.
• W3210601188 hasConcept C49105822 @default.
• W3210601188 hasConcept C54355233 @default.
• W3210601188 hasConcept C71924100 @default.
• W3210601188 hasConcept C86803240 @default.
• W3210601188 hasConcept C90924648 @default.
• W3210601188 hasConceptScore W3210601188C104317684 @default.
• W3210601188 hasConceptScore W3210601188C114851261 @default.
• W3210601188 hasConceptScore W3210601188C126322002 @default.
• W3210601188 hasConceptScore W3210601188C142462285 @default.
• W3210601188 hasConceptScore W3210601188C156719811 @default.
• W3210601188 hasConceptScore W3210601188C159047783 @default.
• W3210601188 hasConceptScore W3210601188C182707283 @default.

• next